|
|
|
|
|
|||||||
|
Session 5
Oral Abstract Session
Epidemiology and Infection Control Monday, 10 am - 12:30 pm 6C |
| Moderators | Connie Celum, Univ. of Washington, Seattle and Susan Buchbinder, San Francisco Dept. of Publ. Hlth.,CA | ||
| 10:00 11. | HIV Prevalence in the United States, 2000 P. L. Fleming*, R. H. Byers, P. A. Sweeney, D. Daniels, J. M. Karon, and R. S. Janssen CDC, Atlanta, GA
| ||
| 10:15 12. | HIV Infection among Men with Infectious Syphilis in Chicago, 1998-2000 C. A . Ciesielski*1,2, and S. Boghani1 1Chicago Dept. of Publ. Hlth., IL and 2CDC, Atlanta, GA
| ||
| 10:30 13. | Lower Mortality in Ambulatory HIV-Infected Patients who Initiate Antiretroviral Therapy at Higher CD4+ Cell Counts F. Palella*1, M. Knoll1, J. Chmiel1, A. Moorman2, K. Wood3, A. Greenberg2, and S. Holmberg2 for the HIV Outpatient Study (HOPS) Investigators 1Northwestern Univ., Chicago, IL; 2CDC, Atlanta, GA; and 3Cerner Corp., Vienna, VA
| ||
| 10:45 14. | Deaths from Non-AIDS-Related Diseases Have Increased as a Proportion of Deaths of HIV-Infected Persons since the Advent of HAART M. I. Wolfe*, D. L. Hanson, R. Selik, and D. L. Swerdlow CDC, Atlanta, GA
| ||
| 11:00 15. | Acceptability, Behavioral Impact, and Possible Efficacy of Post-Sexual-Exposure Chemoprophylaxis (PEP) for HIV M. Schechter*1 , R. F. Lago1 , R. Ismerio1 , A. B. Mendelsohn2, and L. H. Harrison2 1Univ. Federal do Rio de Janeiro, Brazil and 2Univ. of Pittsburgh, PA
| ||
| 11:15 16. | Outbreak of HIV-1 and HCV Infection among Illegal Blood Donors in China L. Zhang*1, Y. Cao2, J. Yu1, T. He1, W. Yu1, Z. Chen1, N. Yin2, S. Mei2, Z. Zhou2, Y. He2, W. Lu2, Z. Chen1, and D. Ho1 1 Aaron Diamond AIDS Res. Ctr., Rockefeller Univ., New York, NY and 2Natl. Ctr. for AIDS Prevention and Control, Chinese Academy of Preventive Med., Beijing
| ||
| 11:30 17. | Spreading of a Non-B Recombinant Form in Seroconverting IVDUs S. Jost1, S. Yerly*1, D. Kaufmann2, M. Monnat2, A. Telenti2, J. P. Chave2, L. Kaiser1, P. Burgisser2, M. Flepp3, and L. Perrin1 1Geneva Univ.; 2Lausanne Univ.; and 3Zurich Univ., Switzerland
| ||
| 11:45 18. | Tracking the Worldwide Subtype C Epidemic C. Kuiken*, U. R. Smith, D. Lang, and T. Bhattacharya Los Alamos Natl. Lab., NM
| ||
| 12:00 19. | Detection of Human Immunodeficiency Virus (HIV) Type 1 and Type 2 RNA and DNA in Vaginal Secretions among Women in Senegal, West Africa C. W. Critchlow*1 , S. Hawes1, M. Redman1, P. Sow2, and N. Kiviat1 1Univ. of Washington, Seattle and 2Univ. of Dakar, Senegal, West Africa
| ||
| 12:15 20. | Factors Associated with Clinical Progression in HIV-2-Infected Patients Included in the French ANRS Cohort S. Matheron*1, S. Pueyo2, F. Damond3, P. Campa1, F. Simon4, G. Chêne2, and F. Brun-Vezinet3 for the French HIV-2 Cohort Study Group 1,3Bichat-Claude Bernard Hosp., Paris; 2INSERM U330, Bordeaux; and 4CHU Rouen, France
|
